‘For sustained growth, India needs to negotiate favourable trade agreements’

CK Govil, CMD, Activair Airfreight said, “Tariffs significantly affect Indian pharma exports by raising costs and reducing competitiveness in global markets. While India is a leading supplier of affordable generics, higher tariffs in importing countries can restrict access, disrupt supply chains, and erode market share. This may also discourage innovation and investments. For sustained growth, India needs to negotiate favourable trade agreements and push for tariff reductions to maintain its global pharma leadership.”